I tend to prefer Cosentyx and Tremfya since they have the joint indication. Do you think these are coming for the other drugs in these classes?
Featuring Saakshi Khattri , MD |

Assistant Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published April 28, 2022
Loading...
Loading...
Loading...
Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved